|
Jan 22
|
Evotec SE: Invitation to Conference Call
|
|
Jan 22
|
UPDATE 1-Evotec says it promptly reported share trades withheld by former CEO
|
|
Jan 10
|
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
|
|
Dec 19
|
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
|
|
Dec 6
|
Evotec-partner Jingxin Receives Approval for EVT201 in China
|
|
Dec 4
|
Evotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%
|
|
Dec 1
|
‘From Hype to Clinical‘: Cowen Suggests 2 AI Healthcare Stocks to Consider
|
|
Nov 15
|
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
|
|
Nov 12
|
Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
|
|
Nov 7
|
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
|
|
Nov 7
|
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
|
|
Nov 1
|
Evotec SE to Announce Results for the First Nine Months 2023 on 08 November 2023
|
|
Aug 29
|
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
|